Summary
Early post-operative local or systemic administration of 5-fluorouracil (5-FU) is under investigation as a means to improve outcome after resection of intestinal malignancies. It is therefore quite important to delineate accurately its potentially negative effects on anastomotic repair. Five groups (n = 24) of rats underwent resection and anastomosis of both ileum and colon: a control group and four experimental groups receiving daily 5-FU, starting immediately after operation or after 1, 2 or 3 days. Within each group, the drug (or saline) was delivered either intraperitoneally (n = 12) or intravenously (n = 12). Animals were killed 7 days after operation and healing was assessed by measurement of anastomotic bursting pressure, breaking strength and hydroxyproline content. In all cases, 5-FU treatment from the day of operation or from day 1 significantly (P < 0.025) and severely suppressed wound strength; concomitantly, the anastomotic hydroxyproline content was reduced. Depending on the location of the anastomosis and the route of 5-FU administration, even a period of 3 days between operation and first dosage seemed insufficient to prevent weakening of the anastomosis. The effects of intravenous administration, though qualitatively similar, were quantitatively less dramatic than those observed after intraperitoneal delivery. Post-operative treatment with 5-FU, if started within the first 3 days after operation, is detrimental to anastomotic strength and may compromise anastomotic integrity.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Cunliffe, W. J. & Sugarbaker, P. H. (1989). Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76: 1082–1090.
de Waard, J. W. D., Wobbes, T. & Hendriks, T. (1993). Early post-operative 5-fluorouracil does not affect the healing of experimental intestinal anastomoses. Int J Colorect Dis 8: 175–178.
de Waard, J. W. D., Wobbes, T., de Man, B. M., van der Linden, C. J. & Hendriks, T. (1995a). Postoperative levamisole may compromise early healing of experimental intestinal anastomoses. Br J Cancer 72: 456–460.
de Waard, J. W. D., Wobbes, T., van der Linden, C. J. & Hendriks, T. (1995b). Vitamin A may promote 5-fluorouracil-suppressed healing of experimental intestinal anastomoses. Arch Surg 130: 959–965.
de Waard, J. W. D., de Man, B. M., Wobbes, T., van der Linden, C. J. & Hendriks, T. (1998). Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil. Eur J Cancer 34: 162–167.
Fielding, L. P., Hittinger, R., Grace, R. H. & Fry, J. S. (1992). Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. Lancet 340: 502–506.
Fisher, B., Gunduz, N. & Saffer, E. (1983). Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 43: 1488–1492.
Fuchs, C. S. & Mayer, R. J. (1995). Adjuvant chemotherapy for colon and rectal cancer. Semin Oncol 22: 472–487.
Goldie, J. H. & Coldman, A. J. (1985). Genetic instability in the development of drug resistance. Semin Oncol 12: 222–230.
Golub, R., Golub, R. W., Cantu, R. Jr & Stein, D. H. (1997). A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J Am Coll Surg 184: 364–372.
Graf, W., Weiber, S., Glimelius, B., Jiborn, H., Påhlman, L. & Zederfeldt, B. (1992). Influence of 5-fluorouracil and folinic acid on colonic healing: an experimental study in the rat. Br J Surg 79: 825–828.
Graf, W., Weiber, S., Jiborn, H., Påhlman, L., Glimelius, B. & Zederfeldt, B. (1994a). The roles of nutritional depletion and drug concentration in 5-fluorouracil-induced inhibition of colonic healing. J Surg Res 56: 452–456.
Graf, W., Ivarsson, M., Gerdin, B., Hellsing, K., Påhlman, L. & Glimelius, B. (1994b). The influence of early postoperative chemotherapy on human wound healing. J Surg Res 57: 394–400.
Harris, D. T. & Mastrangelo, M. J. (1991). Theory and application of early systemic therapy. Semin Oncol 18: 493–503.
Hendriks, T. & Mastboom, W. J. B. (1990). Healing of experimental intestinal anastomoses: parameters for repair. Dis Colon Rectum 33: 891–901.
Martens, MFWC, Hendriks, T., Wobbes, T. & de Pont, JJHHM (1992). Intraperitoneal cytostatics impair early post-operative collagen synthesis in experimental intestinal anastomoses. Br J Cancer 65: 649–654.
Påhlman, L. (1995). Open trials in colorectal cancer. Eur J Surg Oncol 21: 347–351.
Rustum, Y. M., Harstrick, A., Cao, S., Vanhoefer, U., Yin, M. B., Wilke, H. & Seeber, S. (1997). Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol 15: 389–400.
Saltz, L. B. & Kelsen, D. P. (1997). Adjuvant treatment of colorectal cancer. Annu Rev Med 48: 191–202.
Sinicrope, F. A. & Sugarman, S. M. (1995). Role of adjuvant therapy in surgically resected colorectal carcinoma. Gastroenterology 109: 984–993.
Thornton, F. J. & Barbul, A. (1997). Healing in the gastrointestinal tract. Surg Clin N Am 77: 549–573.
Vaughn, D. J. & Haller, D. G. (1997). Adjuvant therapy for colorectal cancer: past accomplishments, future directions. Cancer Invest 15: 435–447.
Weiber, S., Graf, W., Glimelius, B., Jiborn, H., Påhlman, L. & Zederfeldt, B. (1994). Experimental colonic healing in relation to timing of 5-fluorouracil therapy. Br J Surg 81: 1677–1680.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
van der Kolk, B., de Man, B., Wobbes, T. et al. Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine?. Br J Cancer 79, 545–550 (1999). https://doi.org/10.1038/sj.bjc.6690086
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690086
Keywords
This article is cited by
-
The effects of bevacizumab on intestinal anastomotic healing in rabbits
Surgery Today (2016)
-
Multimodale onkologische Therapiekonzepte, Chemotherapie und Immunsuppression
Der Chirurg (2013)
-
Effects of oxaliplatin and 5-fluorouracil on the healing of colon anastomoses
Surgery Today (2009)
-
The Effect of Capecitabine on the Healing of Colonic Anastomoses in Rats
Diseases of the Colon & Rectum (2007)